Condition
PD-L1 clinical trials and research
As of November 12, 2026, Find a Trial lists 4 PD-L1 clinical trials that are recruiting, at sites in 2 countries (most in China (3), United States (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest PD-L1 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Low-dose local radiotherapy plus pucotenlimab with standard chemotherapy for advanced pancreatic cancer | Phase 1/2 | Hangzhou, Zhejiang | Recruiting | Dec 31, 2025 |
| Imaging PD-L1 Expression in Cancers Using 68Ga-NK224 PET | — | Xiamen, Fujian | Recruiting | Dec 31, 2024 |
| Testing a blood test to predict response to cancer immunotherapy | — | Norwich, Connecticut and 2 other locations | Recruiting | Oct 10, 2024 |
| Combining Envafolimab with Chemoradiotherapy for Advanced Nasopharyngeal Cancer | Phase 2 | Guangzhou, Guangdong | Recruiting | May 31, 2022 |
All recruiting trials (4)
-
Low-dose local radiotherapy plus pucotenlimab with standard chemotherapy for advanced pancreatic cancer
This trial tests whether adding low-dose local radiation and the PD-1 blocker pucotenlimab to standard chemotherapy can help people with advanced, unresectable pancreatic cancer.
-
Imaging PD-L1 Expression in Cancers Using 68Ga-NK224 PET
This study is testing a new type of PET scan to see if it can accurately measure a protein in cancer tumors for people who have just been diagnosed or have already been treated for cancer.
-
Testing a blood test to predict response to cancer immunotherapy
This study is testing a blood test to see if it can predict how well people with advanced cancer will respond to a specific type of immunotherapy.
-
Combining Envafolimab with Chemoradiotherapy for Advanced Nasopharyngeal Cancer
This study is testing if combining a new drug called Envafolimab with standard chemotherapy and radiation can help people with advanced nasopharyngeal cancer live longer without their cancer getting worse.
Related topics
Quick answers
How many PD-L1 clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.